BRCA1 and neoplasm: Although a portion of each tumor subtype contain known cell signaling defects in a single pathway, such as the BRCA1 pathway, it is not feasible to identify, test, develop, and produce a rAAV vector targeting each individual component of the mutant BRCA1 signaling cascade.